Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 10.58% vs 18.91% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 124.71% vs 79.49% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -76.44% vs 536.52% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -25.17% vs -7.74% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Porton Pharma Solutions Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 1.21% vs -5.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 10.58% vs 18.91% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 6.78% vs -80.27% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 124.71% vs 79.49% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -80.61% vs -7.14% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -76.44% vs 536.52% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 32.10% vs -37.69% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -25.17% vs -7.74% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






